强生:IMAAVY获FDA批准用于治疗罕见血液疾病

智通财经
7 hours ago
【强生:IMAAVY获FDA批准用于治疗罕见血液疾病】当地时间8月24日,强生公司宣布,美国食品药品监督管理局已批准IMAAVY用于治疗成人和12岁及以上儿科患者的温抗体型自身免疫性溶血性贫血。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10